{
    "clinical_study": {
        "@rank": "161639", 
        "acronym": "ODIN Junior", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D (10 microgram/day)", 
                "arm_group_type": "Experimental", 
                "description": "Tablets with 10 microgram vitamin D3 (cholecalciferol) daily for 20 weeks."
            }, 
            {
                "arm_group_label": "Vitamin D (20 microgram/day)", 
                "arm_group_type": "Experimental", 
                "description": "Tablets with 20 microgram vitamin D3 (cholecalciferol) daily for 20 weeks."
            }, 
            {
                "arm_group_label": "Placebo control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Tablets with 0 microgram vitamin D daily for 20 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The main purpose of this study is to investigate whether and in which doses vitamin D intake\n      is needed in order to maintain an adequate vitamin D status in 4-8 year-old Danish children\n      during wintertime."
        }, 
        "brief_title": "The Effect of Vitamin D Supplements on Vitamin D Status, Cardiometabolic Health and Immune Defense in Danish Children", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Vitamin D Deficiency", 
        "condition_browse": {
            "mesh_term": "Vitamin D Deficiency"
        }, 
        "detailed_description": {
            "textblock": "The main objective of ODIN Junior is to investigate whether and in which doses vitamin D\n      intake is needed in order to maintain serum 25(OH)D concentrations above deficiency and\n      insufficiency cut-offs (30 nmol/L and 50 nmol/L, respectively) in 4-8 year-old Danish\n      children during the winter time. The children will be randomized to receive tablets with\n      either 10 micrograms/day or 20 microgram/day of vitamin D3 (cholecalciferol), corresponding\n      to one and two times the recommended daily intake in children, or placebo for 20 weeks.\n      Measurements and blood sampling will be performed before the beginning and by the end of the\n      intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  4-8 years at the start of the intervention\n\n          -  healthy\n\n          -  of white, Danish/European origin\n\n          -  children must be Danish-speaking\n\n          -  parents must read and speak Danish\n\n          -  not planning a winter vacation south of a latitude of 51\u00b0North (corresponding to\n             Surrey, England)\n\n        Exclusion Criteria:\n\n          -  diseases that may interfere with vitamin D or calcium metabolism\n\n          -  intake of  medication known to affect vitamin D or calcium metabolism\n\n          -  use of vitamin D containing supplements \u2265 4 days/week the last 8 weeks before\n             intervention start and use of any vitamin D containing supplements the last 4 weeks\n             before intervention start\n\n          -  concomitant participation in other studies involving dietary supplements or blood\n             sampling\n\n          -  serum calcium > 2.7 mmol/L at baseline"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "8 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "130", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02145195", 
            "org_study_id": "D214", 
            "secondary_id": "European Commission"
        }, 
        "intervention": {
            "arm_group_label": [
                "Vitamin D (10 microgram/day)", 
                "Vitamin D (20 microgram/day)"
            ], 
            "intervention_name": "Vitamin D3 (cholecalciferol)", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vitamin D", 
            "Children", 
            "Supplements", 
            "Cardiometabolic markers", 
            "Immune defense", 
            "Bone turnover", 
            "Muscle strength"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "number_of_arms": "3", 
        "official_title": "Food-based Solutions for Optimal Vitamin D Nutrition and Health Through the Life Cycle (ODIN) Junior", 
        "other_outcome": [
            {
                "description": "Blood pressure, insulin, cholesterols etc.", 
                "measure": "Change in cardio-metabolic markers", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 20 weeks"
            }, 
            {
                "description": "Production of cytokines in whole blood cultures. Expression of immune markers and antiviral and antimicrobial peptides.", 
                "measure": "Change in markers of immune defense", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 20 weeks"
            }, 
            {
                "description": "Maximum hand grip strength.", 
                "measure": "Change in muscle strength", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 20 weeks"
            }, 
            {
                "description": "Assessed by questionnaire", 
                "measure": "Dietary intake of vitamin D and calcium", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 20 weeks"
            }
        ], 
        "overall_contact": {
            "email": "cm@nexs.ku.dk", 
            "last_name": "Christian M\u00f8lgaard, PhD, MD", 
            "phone": "+45 35332516"
        }, 
        "overall_contact_backup": {
            "email": "ctd@nexs.ku.dk", 
            "last_name": "Camilla T Damsgaard, PhD", 
            "phone": "+45 35332221"
        }, 
        "overall_official": {
            "affiliation": "Section of Peadiatric and International Nutrition, Department of Nutrition, Exercise and Sports, University of Copenhagen", 
            "last_name": "Christian M\u00f8lgaard, PhD, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Serum concentrations of total 25-hydroxyvitamin D [25(OH)D]", 
            "measure": "Change in vitamin D status", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 20 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02145195"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Copenhagen", 
            "investigator_full_name": "Christian M\u00f8lgaard", 
            "investigator_title": "MD, Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Waist circumference, body weight, height, body mass index (BMI) and BMI z-scores.", 
                "measure": "Change in anthropometric measurements", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 20 weeks"
            }, 
            {
                "description": "Fat mass, fat mass index (kg/m2), fat free mass and fat free mass index (kg/m2).", 
                "measure": "Change in body composition", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 20 weeks"
            }, 
            {
                "description": "Serum calcium (adjusted for albumin) evaluated after the first visit has been completed for all children, and after the second visit.", 
                "measure": "Serum calcium", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and 20 weeks"
            }
        ], 
        "source": "University of Copenhagen", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University College Cork", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Surrey", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}